|
|
||||||||
Concise Review |
The Department of Molecular Oncology, Genentech, Inc., South San Francisco, California, USA
Key Words. Thrombopoietin • c-mpl • Platelets • Stem cells • Thrombocytopenia • Hematopoiesis
Correspondence:
Dr. Frederic J. de Sauvage, Genentech, Inc., One DNA Way, South San Francisco, CA 94080, USA.
Thrombopoietin (TPO) is the primary regulator of megakaryocyte (Meg) and platelet production. Its receptor, c-mpl, is a member of the cytokine receptor superfamily. Major insight into the physiological role of this receptor/ligand pair came from the study of mice carrying disrupted alleles of these two genes. Both TPO and c-mpl knockout mice are viable, but have a 90% reduction in platelet counts. Their thrombocytopenia is caused by a reduction in progenitor cell numbers and a decrease in Meg ploidy. However, the Megs and platelets produced in the absence of TPO or c-mpl appear morphologically and functionally normal indicating that, in vivo, the main role of TPO is to control their numbers, rather than their maturation. In addition to its effect on the Meg lineage, TPO also affects hematopoietic stem cells as measured by a reduction of the repopulating capacity of bone marrow cells from c-mpl-deficient mice. Finally, analysis of these gene targeted mice provided substantial evidence to a model where the circulating TPO level is directly regulated by the platelet mass through binding to c-mpl receptors present at the platelet surface. This elegant feedback mechanism allows a tight regulation of the amount of TPO available to stimulate megakaryocytopoiesis.
This article has been cited by other articles:
![]() |
S. Jeanpierre, F. E. Nicolini, B. Kaniewski, C. Dumontet, R. Rimokh, A. Puisieux, and V. Maguer-Satta BMP4 regulation of human megakaryocytic differentiation is involved in thrombopoietin signaling Blood, October 15, 2008; 112(8): 3154 - 3163. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Dordelmann, R. Telgmann, E. Brand, C. Hagedorn, B. Schroer, S. Hasenkamp, P. Baumgart, P. Kleine-Katthofer, M. Paul, and S.-M. Brand-Herrmann Functional and Structural Profiling of the Human Thrombopoietin Gene Promoter J. Biol. Chem., September 5, 2008; 283(36): 24382 - 24391. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Sebastian, M. Serra, A. Yeramian, N. Serrat, J. Lloberas, and A. Celada Deacetylase Activity Is Required for STAT5-Dependent GM-CSF Functional Activity in Macrophages and Differentiation to Dendritic Cells J. Immunol., May 1, 2008; 180(9): 5898 - 5906. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. H. Zhang, S. Basu, F. Wu, C. G. Begley, C. J. M. Saris, A. R. Dunn, A. W. Burgess, and F. Walker Macrophage-colony stimulating factor is required for the production of neutrophil-promoting activity by mouse embryo fibroblasts deficient in G-CSF and GM-CSF J. Leukoc. Biol., October 1, 2007; 82(4): 915 - 925. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-G. Kopp, S. T. Avecilla, A. T. Hooper, S. V. Shmelkov, C. A. Ramos, F. Zhang, and S. Rafii Tie2 activation contributes to hemangiogenic regeneration after myelosuppression Blood, July 15, 2005; 106(2): 505 - 513. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. D. Dahlen, V. C. Broudy, and J. G. Drachman Internalization of the thrombopoietin receptor is regulated by 2 cytoplasmic motifs Blood, July 1, 2003; 102(1): 102 - 108. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. M. P. Joseph, Y. Zavros, J. L. Merchant, and D. Kirschner A model for integrative study of human gastric acid secretion J Appl Physiol, April 1, 2003; 94(4): 1602 - 1618. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. J. Blake, B. J. Jenkins, R. J. D'Andrea, and T. J. Gonda Functional cross-talk between cytokine receptors revealed by activating mutations in the extracellular domain of the {beta}-subunit of the GM-CSF receptor J. Leukoc. Biol., December 1, 2002; 72(6): 1246 - 1255. [Abstract] [Full Text] [PDF] |
||||
![]() |
E.-M. Wolber and W. Jelkmann Thrombopoietin: The Novel Hepatic Hormone Physiology, February 1, 2002; 17(1): 6 - 10. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-H. Kie, W.-I. Yang, M.-K. Lee, T.-J. Kwon, Y.-H. Min, H.-O. Kim, H.-S. Ahn, S.-A. Im, H.-L. Kim, H.-Y. Park, et al. Decrease in Apoptosis and Increase in Polyploidization of Megakaryocytes by Stem Cell Factor During Ex Vivo Expansion of Human Cord Blood CD34+ Cells Using Thrombopoietin Stem Cells, January 1, 2002; 20(1): 73 - 79. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. D. Demetri Targeted Approaches for the Treatment of Thrombocytopenia Oncologist, October 1, 2001; 6(2008): 15 - 23. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. D. Car and V. M. Eng Special Considerations in the Evaluation of the Hematology and Hemostasis of Mutant Mice Vet. Pathol., January 1, 2001; 38(1): 20 - 30. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. J. Lane, S. Dias, K. Hattori, B. Heissig, M. Choy, S. Y. Rabbany, J. Wood, M. A. S. Moore, and S. Rafii Stromal-derived factor 1-induced megakaryocyte migration and platelet production is dependent on matrix metalloproteinases Blood, December 15, 2000; 96(13): 4152 - 4159. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. A. Harker, L. K. Roskos, U. M. Marzec, R. A. Carter, J. K. Cherry, B. Sundell, E. N. Cheung, D. Terry, and W. Sheridan Effects of megakaryocyte growth and development factor on platelet production, platelet life span, and platelet function in healthy human volunteers Blood, April 15, 2000; 95(8): 2514 - 2522. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-C. Shih, M. C.-T. Hu, J. Hu, Y. Weng, P. J. Yazaki, J. Medeiros, and S. J. Forman A secreted and LIF-mediated stromal cell-derived activity that promotes ex vivo expansion of human hematopoietic stem cells Blood, March 15, 2000; 95(6): 1957 - 1966. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Yagi, K. A. Ritchie, E. Sitnicka, C. Storey, G. J. Roth, and S. Bartelmez Sustained ex vivo expansion of hematopoietic stem cells mediated by thrombopoietin PNAS, July 6, 1999; 96(14): 8126 - 8131. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| STEM CELLS | THE ONCOLOGIST | CME | ALPHAMED PRESS JOURNALS |